Ofatumumab-induced severe reactivation of psoriasis in a patient with multiple sclerosis

Mult Scler. 2024 Jul;30(8):1086-1088. doi: 10.1177/13524585241260564. Epub 2024 Jun 15.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized* / adverse effects
  • Female
  • Humans
  • Middle Aged
  • Multiple Sclerosis / drug therapy
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy
  • Psoriasis* / chemically induced
  • Psoriasis* / drug therapy

Substances

  • Antibodies, Monoclonal, Humanized
  • ofatumumab